COVID-19: Vaccines and Therapeutics

Jan 26, 2021
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.
Jan 25, 2021
Pfizer Inc. has completed enrolling children aged 12 to 15 in a COVID-19 vaccine study, the drug maker confirmed. 
Jan 25, 2021
This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
Jan 22, 2021
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Jan 22, 2021
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
Jan 21, 2021
President Biden today took a number of actions, including signing a series of executive orders (EOs), aimed at addressing the COVID-19 pandemic.
Jan 20, 2021
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
Jan 20, 2021
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use.
Jan 19, 2021
The Department of Health and Human Services announced a $20 million investment in several initiatives that will help increase data sharing between health information exchanges and immunization information systems.